Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Imagery of Solid Tumors With Indocyanine Green
NCT02280954Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Nov 2013
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in solid tumor, sponsored by University of Pennsylvania. Primary endpoint: The ability of the imaging system to detect the expression of the ICG in the nodule/mass (i.e tumor) and discern the uptake of the dye by the tumor. Started Nov 2013; status: completed.
02
Drugs
indocyanine green
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02280954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280954.